A New Therapy of Type 2 Diabetes: DPP-4 Inhibitors

QR Code

A New Therapy of Type 2 Diabetes: DPP-4 Inhibitors

None

Saved in:

Bibliographic Details
Main Author:	Ábel, Tatjana
Format:	Electronic Book Chapter
Language:	English
Published:	IntechOpen 2011
Subjects:	Health Sciences
Online Access:	https://www.intechopen.com/chapters/21462
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

NeSyDPP-4: discovering DPP-4 inhibitors for diabetes treatment with a neuro-symbolic AI approach
by: Delower Hossain, et al.
Published: (2025-07-01)

Frailty-stratified effectiveness of SGLT2 inhibitors versus DPP-4 inhibitors and GLP-1 receptor agonists on pulmonary outcomes in type 2 diabetes: a nationwide cohort studyResearch in context
by: Lin-Chieh Meng, et al.
Published: (2025-07-01)

Cost Analysis of DPP4 and SGLT2 Inhibitors - “Dilemma of the Prescribing Physician - Which Brand to Choose?”
by: Hiteswar Saikia, et al.
Published: (2024-06-01)

Antidiabetic Therapy in Type 2 Diabetic Patients on Hemodialysis
by: Biesenbach, Georg, et al.
Published: (2011)

STUDI IN SILICO POTENSI SENYAWA ALLIIN BAWANG PUTIH (Allium sativum) SEBAGAI INHIBITOR DPP-4 PADA DIABETES MELLITUS
by: Martina Kurnia Rohmah
Published: (2018-03-01)

DPP-4 inhibitor anagliptin protects against hypoxia-induced cytotoxicity in cardiac H9C2 cells
by: Yunxiang Ma, et al.
Published: (2019-12-01)

Type 2 Diabetes and Fibrinolysis
by: Staško, Ján, et al.
Published: (2011)

Perspectives of Cell Therapy in Type 1 Diabetes
by: Zanone, Maria M., et al.
Published: (2011)

Carbohydrate Derivatives and Glycomimetic Compounds in Established and Investigational Therapies of Type 2 Diabetes Mellitus
by: Somsák, László, et al.
Published: (2011)

Pathophysiology in Type 2 Diabetes – Type 2 Diabetes and Sleep-Disordered Breathing/Sleep Apnea – Role of Adipocytokines
by: Kishida, Ken
Published: (2011)

Role of Incretin, Incretin Analogues and Dipeptidyl Peptidase 4 Inhibitors in the Pathogenesis and Treatment of Diabetes Mellitus
by: Papazafiropoulou, Athanasia K., et al.
Published: (2011)

Mechanisms of beneficial effects of DPP-4 inhibitors as a promising perspective for the prevention/treatment of the disruption of cardio-cerebrovascular homeostasis
by: Katarina Tomović Pavlović, et al.
Published: (2025-07-01)

Effects of Type 2 Diabetes on Arterial Endothelium
by: Arce-Esquivel, Arturo A., et al.
Published: (2011)

Antihypertensive Treatment in Type 2 Diabetic Patients
by: Carella, Angelo Michele
Published: (2011)

Diabetes Type 1 and 2: What is Behind a Classification?
by: Mimbacas, Adriana, et al.
Published: (2011)

Type 2 Diabetes and Pancreatic Cancer – A Possible Reason
by: Pour, Parviz M
Published: (2011)

The Role of the Endocannabinoid System in the Pathogeny of Type 2 Diabetes
by: Dinu, Robert, et al.
Published: (2011)

Burden of Diabetes Type 2 Through Modelling and Simulation
by: Atanasijević-Kunc, Maja, et al.
Published: (2011)

Detection of Silent Ischemia in Patients with Type 2 Diabetes
by: Emilia, Babes Elena, et al.
Published: (2011)

Endothelial Dysfunction and Therapeutic Intervention in Type 2 Diabetes
by: Páez, Fernando Grover
Published: (2011)

Targeting AMPK for Therapeutic Intervention in Type 2 Diabetes
by: Kodiha, Mohamed, et al.
Published: (2011)

Bariatric Surgery on Obese Type 2 Diabetes Patients
by: Mori, Junichirou, et al.
Published: (2012)

Role of Vitamin D in the Pathogenesis and Therapy of Type 1 Diabetes Mellitus
by: Busta, Agustin, et al.
Published: (2011)

Comparative effectiveness of dipeptidyl peptidase-4 (DPP-4) inhibitors and human glucagon-like peptide-1 (GLP-1) analogue as add-on therapies to sulphonylurea among diabetes patients in the Asia-Pacific region: a systematic review.
by: Martin C S Wong, et al.
Published: (2014-01-01)

The Bidirectional Relationship Between Psychiatry and Type 2 Diabetes Mellitus
by: Rabie, Menan
Published: (2011)

Type 2 Diabetes Mellitus in Family Practice: Prevention and Screening
by: Evans, Philip, et al.
Published: (2011)

Emerging Challenge of Type 2 Diabetes: Prospects of Medicinal Plants
by: Begum, Rokeya, et al.
Published: (2011)

Genetics of Endothelial Damage Associated to Diabetes Mellitus Type 2
by: García, Lorena, et al.
Published: (2011)

Can Bariatric or Metabolic Surgery Cure Type 2 Diabetes?
by: Miguel, Gustavo P. S., et al.
Published: (2011)

Disturbed Chylomicron Metabolism in Type 2 Diabetes - A Preventable Cause of Atherosclerosis?
by: Tomkin, Gerald H., et al.
Published: (2011)

Nuclear Imaging of Glucose Transport/Metabolism – An Interesting Tool to Screen Insulin Resistance, Refine Diagnosis of Type 2 Diabetes, Understand Disease Mechanisms, and/or Evaluate New Therapies
by: Perret, P., et al.
Published: (2011)

Alzheimer’s Disease and Type 2 Diabetes: Different Pathologies and Same Features
by: Carlo, Marta Di, et al.
Published: (2011)

Fulminant Type 1 Diabetes Mellitus in IRS-2 Deficient Mice
by: Arai, Toshiro, et al.
Published: (2011)

Sonographic Imaging of the Peripheral Nerves in Patients with Type 2 Diabetes Mellitus
by: Watanabe, Tsuneo, et al.
Published: (2011)

Treatments for Hypertension in Type 2 Diabetes-Non-Pharmacological and Pharmacological Measurements
by: Masuo, Kazuko, et al.
Published: (2011)

Role of Triglyceride/Fatty Acid Cycle in Development of Type 2 Diabetes
by: Hsieh, Chang-Wen, et al.
Published: (2011)

Impaired Vascular BK Channel Function in Type 2 Diabetes Mellitus
by: Lu, Tong, et al.
Published: (2011)

A Review of Clinical Trials in Emerging Botanical Interventions for Type 2 Diabetes Mellitus
by: Ooi, Cheow Peng, et al.
Published: (2011)

The Role of Genetic Predisposition in Diagnosis and Therapy of Periodontal Diseases in Type 1 Diabetes Mellitus
by: Albrecht, M.G.K.
Published: (2011)

Present Accomplishments and Future Prospects of Cell-Based Therapies for Type 1 Diabetes Mellitus
by: Chhabra, Preeti, et al.
Published: (2011)